Carlos Luzzani

Carlos Luzzani has extensive work experience in various scientific and research roles. Carlos co-founded MultiplAI Health in 2020 and currently serves as the Chief Strategy Officer. Prior to this, Carlos worked at FLENI as a Research Scientist from July 2016 onwards, and previously as a Postdoctoral Fellow from May 2013 to June 2016.

Carlos also worked at the Consejo Nacional de Investigaciones Científicas y Técnicas as a Research Scientist from July 2016 to September 2022.

In addition, Carlos co-founded WeBio in February 2018, where they led efforts to improve the drug development process through bioprinting, collaborating with pharmaceutical companies, startups, and scientific institutions. Carlos held this role until February 2020.

Furthermore, they worked as a Senior Teaching Assistant at Fundación Barceló from April 2013 to April 2017, specifically in the Biochemistry, Immunology, and Nutrition department of the Faculty of Medicine.

Carlos began their career as a Teaching Assistant at the Faculty of Exact and Natural Sciences, UBA in September 2007. Carlos later became a PhD student and completed their studies in March 2013. During their time there, they also served as a Junior Teaching Assistant from September 2007 to March 2009.

Carlos Luzzani's education history is as follows:

From 2002 to 2007, Carlos Luzzani attended the University of Buenos Aires, where they obtained a Bachelor's degree in Biological Sciences with a specialization in Molecular and Cellular Biology.

Starting in 2008 until 2013, Carlos Luzzani pursued their Doctor of Philosophy (PhD) at the University of Buenos Aires. Their research focused on the field of Stem Cell Biology and specifically on the cellular and molecular biology of stem cells.

In 2011 and 2012, Carlos Luzzani returned to the University of Buenos Aires to complete a specialization in Industrial Biotechnology. This program allowed him to gain expertise in the field of biotechnology.

In 2020, Carlos Luzzani undertook a postgraduate program at the Fundación de Estudios Farmacológicos y de Medicamentos (Foundation for Pharmacological and Medicinal Studies) called ICH Good Clinical Practices for Clinical Research. This program equipped him with knowledge and skills related to conducting clinical research in accordance with international guidelines.

Based on the given information, Carlos Luzzani's education history showcases a strong academic background in biology and biotechnology, with a particular focus on stem cell biology and industrial biotechnology. Carlos has also pursued a postgraduate program to enhance their understanding of clinical research practices.